Package 0173-0754-00

{"route": ["ORAL"], "spl_id": "0c7b21d8-3c32-4c65-95cd-cada0421d8e3", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0301730756008", "0301730757005", "0301730761002", "0301730754004", "0301730781000"], "unii": ["U3H27498KS"], "rxcui": ["850087", "850091", "900145", "900156", "900157", "900164", "900165", "900169", "900865", "900866", "900890", "900891", "900983", "900984", "1098608", "1098610", "1146690", "1146692"], "spl_set_id": ["3e2c9a35-6a39-41d7-ad84-3c0bb8894b09"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0173-0754-00)", "package_ndc": "0173-0754-00", "marketing_start_date": "20090706"}], "brand_name": "LAMICTAL XR", "product_id": "0173-0754_0c7b21d8-3c32-4c65-95cd-cada0421d8e3", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "0173-0754", "generic_name": "lamotrigine", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LAMICTAL", "brand_name_suffix": "XR", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "25 mg/1"}], "application_number": "NDA022115", "marketing_category": "NDA", "marketing_start_date": "20090706", "listing_expiration_date": "20261231"}